RK
Rajesh Kumar Sah
About Rajesh Kumar Sah
Data last updated:
Rajesh Kumar Sah is a Director at Jibok Pharmaceuticals Private Limited (since 2007), Director at Jimbiosis Healthcare Private Limited (since 2010) and Director at North Twenty Four Healthcare Limited (since 2017). The companies operate in Pharma, Trading and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹2.43 Cr; the largest is Jibok Pharmaceuticals Private Limited at ₹1.46 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Jibok Pharmaceuticals Private Limited U24232WB2007PTC119509 | Director | 12 Oct 2007 | 2007 | ₹1.46 Cr (FY 2025) | Active |
| Jimbiosis Healthcare Private Limited U85110WB2010PTC155445 | Director | 06 Dec 2010 | 2010 | ₹85.6 Lakh (FY 2025) | Active |
| North Twenty Four Healthcare Limited U74999WB2017PLC222430 | Director | 23 Aug 2017 | 2017 | ₹11.3 Lakh (FY 2022) | Active |
Board colleagues of Rajesh Kumar Sah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pradip Kumar Ghosh | 01717623 | Jibok Pharmaceuticals Private Limited , Jimbiosis Healthcare Private Limited | Director |
| Satyajit Acharjee | 01717645 | Jibok Pharmaceuticals Private Limited , Jimbiosis Healthcare Private Limited | Director |
| Tushar Kanti Ghosh | 01717543 | Jibok Pharmaceuticals Private Limited , Jimbiosis Healthcare Private Limited | Director |
| Ajit Kumar Mazumdar | 07871694 | North Twenty Four Healthcare Limited | Director |
| Arnab Chakraborty | 07871714 | North Twenty Four Healthcare Limited | Director |
| Nepal Roy Adhikari | 07879175 | North Twenty Four Healthcare Limited | Director |
| Prabir Ghosal | 07871715 | North Twenty Four Healthcare Limited | Director |
| Ritu Sah | 07879179 | North Twenty Four Healthcare Limited | Director |
| Sambhu Nath Ghosh | 07871704 | North Twenty Four Healthcare Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Kumar Sah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Kumar Sah
Rajesh Kumar Sah currently holds 3 directorships: Jibok Pharmaceuticals Private Limited (Director, since 12 Oct 2007, revenue ₹1.46 Cr (FY 2025)); Jimbiosis Healthcare Private Limited (Director, since 06 Dec 2010, revenue ₹85.6 Lakh (FY 2025)); North Twenty Four Healthcare Limited (Director, since 23 Aug 2017, revenue ₹11.3 Lakh (FY 2022)).
Rajesh Kumar Sah was first appointed on 12 Oct 2007 as Director at Jibok Pharmaceuticals Private Limited. The most recent appointment on record is 23 Aug 2017 at North Twenty Four Healthcare Limited.
The 3 current companies of Rajesh Kumar Sah that report revenue have a combined latest revenue of ₹2.43 Cr: Jibok Pharmaceuticals Private Limited ₹1.46 Cr (FY 2025); Jimbiosis Healthcare Private Limited ₹85.6 Lakh (FY 2025); North Twenty Four Healthcare Limited ₹11.3 Lakh (FY 2022).
The current boards of Rajesh Kumar Sah's companies include Pradip Kumar Ghosh (Jibok Pharmaceuticals Private Limited), Satyajit Acharjee (Jibok Pharmaceuticals Private Limited), Tushar Kanti Ghosh (Jibok Pharmaceuticals Private Limited), Ajit Kumar Mazumdar (North Twenty Four Healthcare Limited), Arnab Chakraborty (North Twenty Four Healthcare Limited), Nepal Roy Adhikari (North Twenty Four Healthcare Limited), among others.